The flights carried manufactured organs, being developed by United Therapeutics

The flights are also the first in a series of use cases that will touch at least 26 states nationwide

BETA Technologies, Inc. (BETA) (NYSE:BETA), an aerospace and defense company, and the Multistate Collaborative eIPP National Integration Complex today announced the completion of the first electric conventional takeoff and landing ("CTOL") aircraft flights conducted under the U.S. Department of Transportation ("U.S. DOT") and the Federal Aviation Administration ("FAA")’s eVTOL Integration Pilot Program ("eIPP"), the federal government's new initiative to evaluate how Advanced Air Mobility ("AAM") aircraft can safely operate in everyday commercial use within the National Airspace System ("NAS").

The mission—conducted in partnership with the Pennsylvania Department of Transportation, the Virginia Department of Aviation, and the Maryland Aviation Administration—demonstrates BETA's ability to transform mission-critical logistics.

The inaugural campaign demonstrated routine operations across a multistate corridor connecting Virginia and Maryland. The flights covered approximately 275 nautical miles, flying between Virginia Tech/Montgomery Executive Airport (KBCB) in Blacksburg, Virginia; Charlottesville-Albemarle Airport (KCHO) in Charlottesville, Virginia; Frederick Municipal Airport (KFDK) in Frederick, Maryland; and Martin State Airport (KMTN) in Baltimore County, Maryland. This milestone comes just months after BETA was selected to participate in seven of the FAA’s eight eIPP launch programs, more than any other electric aircraft developer.

BETA and United Therapeutics Corporation (NASDAQ:UTHR), a biotech company at the forefront of increasing the supply of transplantable organs through their revolutionary organ manufacturing pipeline, have a long-standing partnership to develop and operate electric CTOL and vertical takeoff and landing ("VTOL") aircraft to deliver the manufactured organ products when they become commercially available. The partnership aims to reduce the cost, increase the reliability, and lower the carbon footprint of large-scale organ delivery operations. United Therapeutic’s subsidiary, Unither Bioelectronics, led by Mikael Cardinal, has advised and partnered with BETA on technologies including autonomy, aircraft aerostructures, and the strategic deployment of charging infrastructure.